Sanjay Tanday. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » Antineoplastic Agents/therapeutic useDisease ProgressionEnzyme Inhibitors/therapeutic useHumansMolecular Targeted TherapyMultiple Myeloma/drug therapyMultiple Myeloma/enzymologyMultiple Myeloma/pathologyProtein-Arginine Deiminase Type 2Protein-Arginine Deiminases/antagonists & inhibitorsProtein-Arginine Deiminases/metabolism
Substances: See more » Antineoplastic AgentsEnzyme InhibitorsPADI2 protein, humanProtein-Arginine Deiminase Type 2Protein-Arginine Deiminases
Year: 2016 PMID: 27425813 DOI: 10.1016/S1470-2045(16)30314-X
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316